Searched for
SANJIV NAVANGUL
RICE Adamas Group expands national footprint with Mumbai Office inaugurationAdamas University and Adamas Tech Consulting have launched a new Mumbai office and the Adamas School of Experiential Learning, offering 10-...- India Inc On The Move 2026: Leaders decode the next phase of AI-driven manufacturingIndia Inc On The Move 2026 in Mumbai will convene manufacturing leaders, tech innovators, and policymakers on February 12, 2026. The event,...
- Mankind Pharma completes Rs 13,768 cr BSV acquisitionMankind Pharma has completed the acquisition of Bharat Serums and Vaccines Ltd for Rs 13,768 crore. This acquisition strengthens Mankind Ph...
- Mankind Pharma competes with EQT-ADIA combo for Rs 14,000 cr buyout of BSV Group from AdventThe buyout of BSV Group (formerly Bharat Serum & Vaccines Ltd) is contested by Mankind Pharma and EQT with ADIA, each offering around Rs 14...
- ETILC’s Innovation Sub-Committee to be a think tank that influences policyVolunteering members of the steering committee Himanshu Jain, Managing Director and Vice President - South East Asia and Indian Sub-Contine...
- Bharat Serums and Vaccines acquires key women health brand Tidilan from Jagdale IndustriesTidilan is used for relaxing uterine muscles to prevent premature labour, among expecting mothers. It belongs to a class of medication call...
- Bharat Serums acquires 26 pc stake in solar power firm AMP Energy C&I One"This solar project resonates our belief in building a greener environment, judiciously using natural resources and renewable sources of en...
- India has scaled its medical infrastructure sufficiently: ET-ILC ForumThe lockdown gave the country and the medical fraternity enough time to prepare and scale infrastructure. The lockdown gave hospitals the t...
- Strengthening ASEAN collaboration will result in assured economic growth: ET-ILC Roundtable with IBDASEAN trade became concentrated in a few extra-regional markets between 2010 and 2018, while less was done to expand intra-regional trade. ...
- Mumbai company working on horse antibodies Covid treatmentThe equine antisera pathway with which the Mumbai-based company is working is already used in treatments against snake bites, rabies and di...
- Johnson and Johnson to offer first TB drug in 40 years for $900J&J said India is eligible for the lowest global price and that it is working on a sustainable access strategy.
- ‘Miracle drug’ for resistant Tuberculosis to be rolled out for trial todayA ‘miracle drug’ to battle multi-drug resistant tuberculosis MDR-TB, and extensively-drug resistant TB (XDR-TB), will be rolled out on Mond...
- Janssen India launches diabetes treatment drugTaken orally once a day, Invokana belongs to a new class of medications which work in a completely different way to other classes of type 2...
- Pharma companies using 'health managers' to help patients and earn revenuesThe companies give patients more than just the daily dose, helping them with counselling, diagnostic tests, freebies, diet or exercise advi...
- Diabetes drugs post fastest sales growthOral anti-diabetes segment grew 29.7% for the nine-month period ended August 2010 over the year ago period compared with 22.9% increase in ...
- Govt's wait for trial may delay cervical cancer immunisation driveThe government will wait for full clinical trial reports on new vaccines for cervical cancer.
- Pharma MNCs want to take a shot at India’s vaccine marketMultinational pharmaceutical companies are now increasingly looking at the Indian vaccine market in a big way. MSD Pharmaceuticals, GlaxoSm...
- Merck subsidiary plans to launch patented drugsMerck Sharp & Dohme (MSD) Pharmaceuticals is betting big on India, an emerging market for its patented and first research-based vaccines an...
- Merck secures 2 patents in India, to pursue moreUS-based Merck has received patent approval from the Indian Patent Office for two of its upcoming drugs for dyslipidemia and obesity.
Load More
